Anders Månsson at DNB Carnegie Småbolagsdag
Iconovo’s new Interim CEO, Anders Månsson, made his first official appearance for the company when he presented Iconovo at DNB Carnegie’s Småbolagsdag…
Iconovo carries out a directed issue of shares of approx. SEK 25 million and a rights issue of shares of approx. SEK 24.6 million
The Board of Directors of Iconovo AB ("Iconovo" or the "Company") has today resolved on a directed share issue of approximately SEK 25 million (the…
Iconovo appoints Anders Månsson as new CEO
Iconovo AB (publ), a leader in the development of inhalable drugs based on proprietary inhalers and dry powder formulations, has today appointed Anders…
Iconovo attends Carnegie Healthcare Webinar
Iconovo CEO Johan Wäborg gives a company presentation at Carnegie Healthcare Webinar. In the video you can hear him go through the company, the strategies…
Iconovo är allt närmare vaccin via inhalering
AFFÄRSVÄRLDEN 2023-02-02:
Iconovo är allt närmare vaccin via inhalering, skriver Affärsvärlden idag och rapporterar om extremt lovande resultat…